Know Cancer

forgot password

The Caris Biorepository Research Protocol

18 Years
Open (Enrolling)

Thank you

Trial Information

The Caris Biorepository Research Protocol

The Caris Biorepository is an effort toward defining the future of medicine incorporating
the discoveries of the genomic era by providing physicians, researchers and scientists
access to quality human specimens and data aimed at improving human health and fighting
disease. This will be accomplished through acquiring and sharing valuable biospecimen
information and clinical outcomes in a collaborative, secure environment. The Caris
Biorepository will bridge the gap and correlate human specimens with clinical and specimen
data valuable to multiple and varying entities interested in advancing science with
precision medicine by targeting disease treatments.

The objective of this project is to develop and implement a state-of-the-science
Biorepository that ensures molecular integrity and clinical relevance of human biospecimens
used in research and clinical medicine. The Caris Biorepository will also provide vital
biospecimens and data to internal researchers and external research collaborators such as
government, academia and industry collaborators for the use of drug development discoveries,
clinically relevant research trials, publications and posters, and the implementation of
future healthcare policies. This project may also impact characterization of trends in
practice patterns and their relation to patient outcomes as well as the economic
implications of differing evaluation, treatment and management paradigms.

Inclusion Criteria:

- 18 years of age or older

- Capacity to provide informed consent

Exclusion Criteria:

- Due to the complexity of state and federal requirements governing the participation
of prisoners in research, prisoners-patients will not be approached for participation
in the Caris Biorepository.

- Minor subjects will not be included in the Caris Biorepository, as it is possible
biospecimens and data may be stored beyond the time limitations of assent and it may
be impracticable to re-consent these subjects once they become adults.

- Individuals who lack the capacity to give informed consent

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.

Outcome Description:

Retention of biospecimen samples with DNA

Outcome Time Frame:

5 years

Safety Issue:


Principal Investigator

Les Paul, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Caris Science, Inc.


United States: Institutional Review Board

Study ID:




Start Date:

November 2010

Completion Date:

November 2025

Related Keywords:

  • Cancer



Lehigh Valley Hospital Allentown, Pennsylvania  18103
Hartford Hospital Hartford, Connecticut  06102-5037
Poudre Valley Hospital Fort Collins, Colorado  80524
Palm Beach Cancer Institute West Palm Beach, Florida  33401
Bend Memorial Clinic Bend, Oregon  97701
CAMC Clinical Trials Charleston, West Virginia  25304
Phoebe Putney Memorial Hospital Albany, Georgia  31703
Eastern Carolina Women's Center New Bern, North Carolina  28562
Overlake Hospital Bellevue, Washington  98004
Breastlink Medical Group Long Beach, California  90806
Banner Health Phoenix, Arizona  85006
John Muir Clinical Research Center Concord, California  94520
Community Cancer Research Foundation Munster, Indiana  46321
The Iowa Clinic, PC West Des Moines, Iowa  50266
Renown Health Reno, Nevada  89502
Comprehensive Cancer Center of Pardee Hendersonville, North Carolina  28791